Takeda Pharmaceutical Co. (TAK) vs United Therapeutics Corporation (UTHR)
- Takeda Pharmaceutical Co. TAK 19.67 +1.13%
- United Therapeutics Corporation UTHR 533.12 −1.55%
Takeda Pharmaceutical Co. and United Therapeutics Corporation are both Drug Manufacturers Specialty & Generic companies. Takeda Pharmaceutical Co. is the larger, with a market value of $61.9B against $23.2B — 2.7× the size. United Therapeutics Corporation trades at the lower P/E: 17.6× against 29.6×. United Therapeutics Corporation grew revenue faster over the last twelve months: 2.49% against 0.66%. United Therapeutics Corporation has the higher net margin (41.6% vs 7.12%) and the higher return on invested capital (23.4% vs 2.88%). Across the 22 metrics below, United Therapeutics Corporation leads on 16 and Takeda Pharmaceutical Co. on 6.
Valuation
Profitability
| Metric | TAK | UTHR | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 65.85% | 86.14% | 53.94% |
| Operating margin | 11.61% | 44.44% | 0.00% |
| Net margin | 7.12% | 41.56% | 0.00% |
| Free cash flow margin | 24.74% | 34.65% | 0.00% |
| Return on equity | 4.42% | 19.32% | (0.40%) |
| Return on assets | 2.15% | 17.33% | (3.32%) |
| Return on invested capital | 2.88% | 23.44% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack